Department of Physiology, School of Medicine, Bezmialem Vakif University, Istanbul, Turkey
Department of Medical Pharmacology, School of Medicine, Giresun University, Giresun, Turkey.
In Vivo. 2020 Sep-Oct;34(5):2507-2516. doi: 10.21873/invivo.12067.
BACKGROUND/AIM: This study was designed to provide further evidence for the interactions between hydrogen sulfide (HS) and nitric oxide (NO) in ischemia/reperfusion (I/R) injury. MATERIALS AND METHODS: Rat hearts were studied with the Langendorff technique using the HS donor sodium hydrosulfide (NaHS, 40 μM) and the cystathionine gamma-lyase (CTH or CSE) inhibitor DL-propargylglycine (PAG, 1 mM). NO synthase inhibitor L-NG-nitroarginine methyl ester (L-NAME, 30 mg/kg, 7 days) was administered before the isolation. The hearts were homogenized for biochemical and molecular analysis. RESULTS: NaHS reversed I/R-induced cardiac performance impairment, increased tissue nitric oxide production and decreased tissue markers for cardiac injury, while L-NAME inhibited these effects. The expression of CTH was increased with PAG, which was suppressed by L-NAME. CONCLUSION: HS and NO increase each other's production suggesting their interaction and cooperation in cardioprotection against I/R injury.
背景/目的:本研究旨在提供更多证据证明硫化氢(HS)和一氧化氮(NO)在缺血/再灌注(I/R)损伤中的相互作用。
材料与方法:使用 HS 供体硫氢化钠(NaHS,40 μM)和半胱氨酸γ-裂解酶(CTH 或 CSE)抑制剂 DL-炔丙基甘氨酸(PAG,1 mM),通过 Langendorff 技术研究大鼠心脏。NO 合酶抑制剂 L-NG-硝基精氨酸甲酯(L-NAME,30 mg/kg,7 天)在分离前给予。将心脏匀浆进行生化和分子分析。
结果:NaHS 逆转了 I/R 引起的心脏功能障碍,增加了组织中一氧化氮的产生,降低了组织中心脏损伤的标志物,而 L-NAME 抑制了这些作用。PAG 增加了 CTH 的表达,而 L-NAME 则抑制了这种表达。
结论:HS 和 NO 增加彼此的产生,表明它们在对抗 I/R 损伤的心脏保护中相互作用和协同。
Exp Biol Med (Maywood). 2017-12
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011-2
Biomolecules. 2024-6-22
Free Radic Biol Med. 2019-3-28
Front Pharmacol. 2018-9-21
Oxid Med Cell Longev. 2018-9-9
Biochem Pharmacol. 2018-3
Biomed Pharmacother. 2017-11-6
Exp Biol Med (Maywood). 2017-12
Biochem Pharmacol. 2017-9-22